Contamination Free Bacterial Swap
Danish Title: Afprøvning af indføringsrør Til Forureningsfri Podning af næsens Bihuler (Den Forureningsfri Podepind)
1 other identifier
interventional
64
1 country
1
Brief Summary
A test of a newly designed device (Contamination free bacterial swab). This device can be used to introduce a standard bacterial swab into the nose without direct or indirect contact with the nasal vestibule.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 6, 2016
CompletedFirst Posted
Study publicly available on registry
October 5, 2016
CompletedStudy Start
First participant enrolled
December 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2018
CompletedApril 11, 2018
April 1, 2018
1.2 years
June 6, 2016
April 10, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Frequency of staphylococcus aureus positive cultures
Comparison of the frequency of staphylococcus aureus positive cultures from the two sides of the nose
1 year
Secondary Outcomes (1)
Frequency of other bacteria in cultures
1 year
Study Arms (2)
Right side
ACTIVE COMPARATORAll included participants serve as their own control. A bacterial swab (Eswab 481CE, Copan Diagnostics, Italy), will be introduced to both sides of the nose (to the middle meatus); on the RIGHT side by using the "Contamination free bacterial swab" introduction device. The "Contamination free bacterial swab" introduction device is a prototype developed for clinical testing.
Left side
ACTIVE COMPARATORAll included participants serve as their own control. A bacterial swab (Eswab 481CE, Copan Diagnostics, Italy) will be introduced to both sides of the nose (to the middle meatus); on the LEFT side using the present day clinical procedure (visually guided introduction).
Interventions
A comparison of the bacteriology in bacterial swabs (Eswab 481CE, Copan Diagnostics, Italy) from the middle meatus. On the RIGHT side using the "Contamination free bacterial swab" introduction device that facilitates the introduction of a bacterial swab into the nose without direct or indirect contact with the nasal vestibule.
Eligibility Criteria
You may qualify if:
- symptoms of upper airway disease
You may not qualify if:
- mental illness
- Need for interpreter
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kåre Håkanssonlead
- Region Capital Denmarkcollaborator
Study Sites (1)
Ørelæge Steffen Ørntoft
Hvidovre, 2650, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Steffen Ørntoft, MD
Steffen Ørntoft, Ear, Nose and Throat specialist clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD, Ph.D
Study Record Dates
First Submitted
June 6, 2016
First Posted
October 5, 2016
Study Start
December 1, 2016
Primary Completion
March 1, 2018
Study Completion
March 1, 2018
Last Updated
April 11, 2018
Record last verified: 2018-04